DBCO-PEG4-MMAF |
| Catalog No.GC62261 |
DBCO-PEG4-MMAF es un conjugado de fÁrmaco-enlazador para ADC con una potente actividad antitumoral mediante el uso del inhibidor de la polimerizaciÓn de tubulina, MMAF, unido a través del enlazador escindible DBCO-PEG4.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2360411-65-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
DBCO-PEG4-MMAF is a drug-linker conjugate for ADC with potent antitumor activity by using the tubulin polymerization inhibitor, MMAF, linked via the cleavable linker DBCO-PEG4.
Average Rating: 5 (Based on Reviews and 21 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *